- Clinical Trials
- April 2025
- 40 Pages
Global
From €888EUR$1,000USD£776GBP
€1110EUR$1,250USD£970GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1421EUR$1,600USD£1,242GBP
€1776EUR$2,000USD£1,552GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1421EUR$1,600USD£1,242GBP
€1776EUR$2,000USD£1,552GBP
- Report
- April 2025
- 200 Pages
Global
From €5649EUR$6,360USD£4,936GBP
€7061EUR$7,950USD£6,170GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €3553EUR$4,000USD£3,104GBP
€4441EUR$5,000USD£3,880GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1066EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1066EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1066EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 70 Pages
Global
From €1066EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1066EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1066EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €888EUR$1,000USD£776GBP
€1110EUR$1,250USD£970GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €888EUR$1,000USD£776GBP
€1110EUR$1,250USD£970GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €888EUR$1,000USD£776GBP
€1110EUR$1,250USD£970GBP
- Report
- December 2025
- 271 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 177 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 381 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 272 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 193 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 131 Pages
Global
From €5196EUR$5,850USD£4,540GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more